L. Verschoor

1.4k total citations
46 papers, 1.1k citations indexed

About

L. Verschoor is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, L. Verschoor has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 8 papers in Epidemiology. Recurrent topics in L. Verschoor's work include Diet and metabolism studies (5 papers), Metabolism, Diabetes, and Cancer (5 papers) and Neuroendocrine Tumor Research Advances (5 papers). L. Verschoor is often cited by papers focused on Diet and metabolism studies (5 papers), Metabolism, Diabetes, and Cancer (5 papers) and Neuroendocrine Tumor Research Advances (5 papers). L. Verschoor collaborates with scholars based in Netherlands, Italy and United States. L. Verschoor's co-authors include Steven W. J. Lamberts, André G. Uitterlinden, K. J. van Dongen, Emilio del Pozo, Gerald M. Reaven, E. del Pozo, Hans de Boer, Janneke Ruinemans‐Koerts, G. P. van Berge Henegouwen and Karel J. van Erpecum and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Blood.

In The Last Decade

L. Verschoor

45 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Verschoor Netherlands 17 623 265 234 134 110 46 1.1k
Mustafa Kulaksızoğlu Türkiye 15 374 0.6× 130 0.5× 184 0.8× 108 0.8× 84 0.8× 54 893
Grażyna Bednarek-Tupikowska Poland 15 275 0.4× 135 0.5× 107 0.5× 118 0.9× 106 1.0× 72 771
P. Clifton‐Bligh Australia 21 330 0.5× 115 0.4× 332 1.4× 201 1.5× 160 1.5× 54 1.1k
Adela Rovira Spain 18 332 0.5× 104 0.4× 201 0.9× 341 2.5× 97 0.9× 53 985
K.M. Mohamed Shakir United States 20 516 0.8× 102 0.4× 277 1.2× 314 2.3× 119 1.1× 52 1.3k
A. Corgnati Italy 13 362 0.6× 118 0.4× 180 0.8× 189 1.4× 103 0.9× 23 899
Gabriela Brenta Argentina 17 1.1k 1.7× 130 0.5× 134 0.6× 222 1.7× 150 1.4× 42 1.3k
Müjde Aktürk Türkiye 21 413 0.7× 166 0.6× 187 0.8× 219 1.6× 79 0.7× 80 1.1k
P. D. Papapetrou Greece 15 297 0.5× 80 0.3× 79 0.3× 123 0.9× 63 0.6× 31 646
Olga T. Hardy United States 12 448 0.7× 298 1.1× 325 1.4× 271 2.0× 159 1.4× 19 1.2k

Countries citing papers authored by L. Verschoor

Since Specialization
Citations

This map shows the geographic impact of L. Verschoor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Verschoor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Verschoor more than expected).

Fields of papers citing papers by L. Verschoor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Verschoor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Verschoor. The network helps show where L. Verschoor may publish in the future.

Co-authorship network of co-authors of L. Verschoor

This figure shows the co-authorship network connecting the top 25 collaborators of L. Verschoor. A scholar is included among the top collaborators of L. Verschoor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Verschoor. L. Verschoor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baur, Xaver, Lygia Therese Budnik, Zhiwei Zhao, et al.. (2015). Health risks in international container and bulk cargo transport due to volatile toxic compounds. Journal of Occupational Medicine and Toxicology. 10(1). 19–19. 30 indexed citations
2.
Verschoor, L., et al.. (2013). Nonoccupational and occupational exposure to isocyanates. Current Opinion in Pulmonary Medicine. 20(2). 199–204. 14 indexed citations
3.
Verschoor, L., et al.. (2012). Gibt es Gefährdungen der Verbraucher durch Begasungsmittelrückstände. Zentralblatt für Arbeitsmedizin Arbeitsschutz und Ergonomie. 1 indexed citations
4.
Verschoor, L., et al.. (2006). Pneumomediastinum as a cause of acute chest pain postpartum. The Journal of Maternal-Fetal & Neonatal Medicine. 19(4). 243–245. 4 indexed citations
5.
Boer, Hans de, et al.. (2005). Glycaemic control without weight gain in insulin requiring type 2 diabetes: 1‐year results of the GAME regimen. Diabetes Obesity and Metabolism. 8(5). 517–523. 9 indexed citations
6.
Boer, Hans de, et al.. (2005). Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism. Diabetes Obesity and Metabolism. 7(3). 211–215. 69 indexed citations
7.
Boer, Hans de, et al.. (2004). Prevention of weight gain in type 2 diabetes requiring insulin treatment. Diabetes Obesity and Metabolism. 6(2). 114–119. 17 indexed citations
8.
Erpecum, Karel J. van, et al.. (1991). Different hepatobiliary effects of oral and transdermal estradiol in postmenopausal women. Gastroenterology. 100(2). 482–488. 65 indexed citations
9.
Wolffenbuttel, Bruce H. R., et al.. (1989). A Randomized Crossover Study of Sulphonylurea and Insulin Treatment in Patients with Type 2 Diabetes Poorly Controlled on Dietary Therapy. Diabetic Medicine. 6(6). 520–525. 17 indexed citations
10.
Baggen, M.G.A., et al.. (1987). Disparate effects of ACTH(1–24) and corticosterone on lipoprotein lipase in rat adipose tissue. Journal of Endocrinology. 114(3). 369–372. 6 indexed citations
11.
Oosterom, R., T. Verleun, André G. Uitterlinden, et al.. (1987). Studies on insulin secretion by monolayer cultures of normal and tumorous human pancreatic cells. Effects of glucose, somatostatin and SMS 201–995. Journal of Endocrinological Investigation. 10(6). 547–552. 6 indexed citations
12.
Verschoor, L., et al.. (1986). ON THE USE OF A NEW SOMATOSTATIN ANALOGUE IN THE TREATMENT OF HYPOGLYCAEMIA IN PATIENTS WITH INSULINOMA. Clinical Endocrinology. 25(5). 555–560. 24 indexed citations
13.
Verschoor, L., et al.. (1986). [Contraception in women with diabetes mellitus].. PubMed. 130(2). 61–3. 1 indexed citations
14.
Verschoor, L., S. W. J. Lamberts, André G. Uitterlinden, & E. del Pozo. (1986). Glucose tolerance during long term treatment with a somatostatin analogue.. BMJ. 293(6558). 1327–1328. 20 indexed citations
15.
Lamberts, Steven W. J., et al.. (1986). A Comparison among the Growth Hormone-Lowering Effects in Acromegaly of the Somatostatin Analog SMS 201-995, Bromocriptine, and the Combination of Both Drugs. The Journal of Clinical Endocrinology & Metabolism. 63(1). 16–19. 75 indexed citations
16.
Verschoor, L., et al.. (1982). Role of exogenous cholesterol in regulation of adrenal steroidogenesis in the rat.. Journal of Biological Chemistry. 257(13). 7666–7671. 51 indexed citations
17.
18.
Verschoor, L., et al.. (1978). Triglyceride turnover in severe chronic non-nephrotic renal failure. Metabolism. 27(8). 879–883. 18 indexed citations
19.
Westbroek, D.L., et al.. (1977). Cryoprecipitated plasma perfusion preservation and cold storage preservation of duct-ligated pancreatic allografts. British journal of surgery. 64(7). 490–493. 13 indexed citations
20.
Verschoor, L., et al.. (1973). Influence of DL-A matching, ALS, and 24-hour preservation on isolated pancreas allograft survival.. PubMed. 5(1). 755–9. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026